Exchange: PNK Industry: Biotechnology
16.84% $0.0683
America/New_York / 31 des 1970 @ 19:00
RATING 2022-02-09 |
---|
B- |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Buy | |
Return On Equity: | Strong Buy | |
Return On Asset: | Strong Sell | |
DE: | Sell | |
P/E: | Strong Sell | |
Price To Book: | Strong Sell |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
1/20 | 2/20 | 3/20 | 4/20 | 1/21 | 2/21 | |
Revenue | n/a | n/a | n/a | n/a | ||
Gr.Profit | n/a | n/a | n/a | |||
Ebit | ||||||
Asset | ||||||
Debt | n/a |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -22.78 | sector: PE -11.58 |
PE RATIO: COMPANY / INDUSTRY |
---|
0x |
Company: PE -22.78 | industry: PE -107.25 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 0 - 0 ( +/- 0.00%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2020-08-12 | Katzaroff James C | Sell | 0 | Common stock |
2020-02-25 | Atwood Brent | Sell | 170 000 | Common Shares |
2020-02-25 | Atwood Brent | Sell | 2 000 000 | Common Shares |
2019-08-14 | Atwood Brent | Buy | 1 250 000 | Common Shares |
2019-08-14 | Atwood Brent | Buy | 77 188 | Common Shares |
INSIDER POWER |
---|
0.00 |
Last 15 transactions |
Buy: 6 428 937 | Sell: 37 895 000 |